• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马动脉炎病毒的一种29K包膜糖蛋白表达可被鼠单克隆抗体识别的中和决定簇。

A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognized by murine monoclonal antibodies.

作者信息

Balasuriya U B, Rossitto P V, DeMaula C D, MacLachlan N J

机构信息

Department of Veterinary Pathology, School of Veterinary Medicine, University of California, Davis 95616.

出版信息

J Gen Virol. 1993 Nov;74 ( Pt 11):2525-9. doi: 10.1099/0022-1317-74-11-2525.

DOI:10.1099/0022-1317-74-11-2525
PMID:7504076
Abstract

A panel of six neutralizing murine monoclonal antibodies (MAbs) to equine arteritis virus (EAV) was produced. The MAbs were characterized by Western immunoblotting assay and competitive ELISA. The six MAbs identify a single neutralization site on a 29K envelope glycoprotein. Deglycosylation of viral proteins prior to immunoblotting showed that the 29K protein is the glycosylated form of a 20K protein. Equine anti-EAV serum also strongly bound the 29K glycoprotein, as well as an unglycosylated protein of 17K. The equine antisera to EAV blocked the binding of a selected MAb to EAV, whereas normal equine serum did not. Two neutralization-resistant escape mutant (EM) variants of the EAV prototype were produced using MAb 6D10. The phenotypic properties of the EM viruses were characterized by neutralization and immunoblotting assays with two MAbs (6D10 and 5G11). The two MAbs failed to neutralize either EM virus, and they did not react in an immunoblot assay with any proteins of the EM viruses. In contrast, binding of the equine antiserum to viral proteins was equivalent with prototype and EM virus strains. These data clearly indicate that a 29K envelope glycoprotein expresses at least one neutralization determinant of EAV.

摘要

制备了一组针对马动脉炎病毒(EAV)的六种中和性鼠单克隆抗体(MAb)。通过Western免疫印迹分析和竞争性ELISA对这些单克隆抗体进行了表征。这六种单克隆抗体识别29K包膜糖蛋白上的一个单一中和位点。免疫印迹前对病毒蛋白进行去糖基化显示,29K蛋白是20K蛋白的糖基化形式。马抗EAV血清也强烈结合29K糖蛋白以及17K的非糖基化蛋白。马抗EAV血清可阻断所选单克隆抗体与EAV的结合,而正常马血清则不能。使用单克隆抗体6D10产生了EAV原型的两个抗中和逃逸突变体(EM)变体。通过用两种单克隆抗体(6D10和5G11)进行中和和免疫印迹分析来表征EM病毒的表型特性。这两种单克隆抗体均不能中和任何一种EM病毒,并且它们在免疫印迹分析中不与EM病毒的任何蛋白质发生反应。相比之下,马抗血清与病毒蛋白的结合在原型病毒株和EM病毒株中是相同的。这些数据清楚地表明,29K包膜糖蛋白表达EAV的至少一个中和决定簇。

相似文献

1
A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognized by murine monoclonal antibodies.马动脉炎病毒的一种29K包膜糖蛋白表达可被鼠单克隆抗体识别的中和决定簇。
J Gen Virol. 1993 Nov;74 ( Pt 11):2525-9. doi: 10.1099/0022-1317-74-11-2525.
2
Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.马动脉炎病毒实验室毒株和野外分离株的中和决定簇:G(L)包膜糖蛋白氨基末端胞外域四个中和位点的鉴定
Virology. 1997 May 26;232(1):114-28. doi: 10.1006/viro.1997.8551.
3
Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus.马动脉炎病毒主要包膜糖蛋白(GL)中一个中和位点的鉴定。
Virology. 1995 Mar 10;207(2):518-27. doi: 10.1006/viro.1995.1112.
4
Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance.使用中和单克隆抗体对马动脉炎病毒分离株进行比较,并鉴定与中和抗性相关的GL中的序列变化。
J Gen Virol. 1995 Sep;76 ( Pt 9):2223-33. doi: 10.1099/0022-1317-76-9-2223.
5
Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone.利用重组嵌合病毒和感染性cDNA克隆的位点特异性诱变对马动脉炎病毒中和决定簇进行表征。
Virology. 2004 Apr 10;321(2):235-46. doi: 10.1016/j.virol.2003.12.015.
6
Monoclonal antibodies directed against conserved epitopes on the nucleocapsid protein and the major envelope glycoprotein of equine arteritis virus.针对马动脉炎病毒核衣壳蛋白和主要包膜糖蛋白上保守表位的单克隆抗体。
J Clin Microbiol. 2000 Jun;38(6):2065-75. doi: 10.1128/JCM.38.6.2065-2075.2000.
7
Monoclonal antibodies to equine arteritis virus proteins identify the GL protein as a target for virus neutralization.针对马动脉炎病毒蛋白的单克隆抗体将GL蛋白鉴定为病毒中和的靶点。
J Gen Virol. 1994 Sep;75 ( Pt 9):2439-44. doi: 10.1099/0022-1317-75-9-2439.
8
Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL.马体内的马动脉炎病毒中和抗体是由大囊膜糖蛋白GL上的一个决定簇诱导产生的。
J Gen Virol. 1995 Aug;76 ( Pt 8):1989-98. doi: 10.1099/0022-1317-76-8-1989.
9
Evaluation of neutralization patterns of the five unique Argentine equine arteritis virus field strains reported.对所报道的五株独特的阿根廷马动脉炎病毒田间毒株的中和模式进行评估。
Rev Argent Microbiol. 2010 Jan-Feb;42(1):11-7. doi: 10.1590/S0325-75412010000100003.
10
Identification of an additional neutralization determinant of equine arteritis virus.马动脉炎病毒另一个中和决定簇的鉴定
Virus Res. 2008 Dec;138(1-2):150-3. doi: 10.1016/j.virusres.2008.09.003. Epub 2008 Oct 25.

引用本文的文献

1
Equine Arteritis Virus Elicits a Mucosal Antibody Response in the Reproductive Tract of Persistently Infected Stallions.马动脉炎病毒在持续感染种公马的生殖道中引发黏膜抗体反应。
Clin Vaccine Immunol. 2017 Oct 5;24(10). doi: 10.1128/CVI.00215-17. Print 2017 Oct.
2
Allelic Variation in CXCL16 Determines CD3+ T Lymphocyte Susceptibility to Equine Arteritis Virus Infection and Establishment of Long-Term Carrier State in the Stallion.CXCL16基因的等位变异决定了CD3⁺ T淋巴细胞对马动脉炎病毒感染的易感性以及种马长期携带状态的形成。
PLoS Genet. 2016 Dec 8;12(12):e1006467. doi: 10.1371/journal.pgen.1006467. eCollection 2016 Dec.
3
Equine Arteritis Virus Uses Equine CXCL16 as an Entry Receptor.
马动脉炎病毒利用马CXCL16作为进入受体。
J Virol. 2016 Jan 13;90(7):3366-84. doi: 10.1128/JVI.02455-15.
4
Equine arteritis virus.马动脉炎病毒。
Vet Microbiol. 2013 Nov 29;167(1-2):93-122. doi: 10.1016/j.vetmic.2013.06.015. Epub 2013 Jul 3.
5
Characterization of equine humoral antibody response to the nonstructural proteins of equine arteritis virus.马对马动脉炎病毒非结构蛋白的体液抗体反应的特征分析。
Clin Vaccine Immunol. 2011 Feb;18(2):268-79. doi: 10.1128/CVI.00444-10. Epub 2010 Dec 8.
6
Development of a fluorescent-microsphere immunoassay for detection of antibodies specific to equine arteritis virus and comparison with the virus neutralization test.一种用于检测马动脉炎病毒特异性抗体的荧光微球免疫测定法的开发及其与病毒中和试验的比较。
Clin Vaccine Immunol. 2008 Jan;15(1):76-87. doi: 10.1128/CVI.00388-07. Epub 2007 Nov 21.
7
Equine arteritis virus.马动脉炎病毒
Theriogenology. 1997 Apr 15;47(6):1275-95. doi: 10.1016/s0093-691x(97)00107-6.
8
Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.通过缺失主要病毒中和结构域产生马动脉炎病毒候选活标记疫苗。
J Virol. 2003 Aug;77(15):8470-80. doi: 10.1128/jvi.77.15.8470-8480.2003.
9
Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity.两种主要包膜蛋白的异源二聚化对于动脉炎病毒的感染性至关重要。
J Virol. 2003 Jan;77(1):97-104. doi: 10.1128/jvi.77.1.97-104.2003.
10
Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.马动脉炎病毒两种主要包膜蛋白以异源二聚体形式表达,对于在用重组委内瑞拉马脑炎病毒复制子颗粒免疫的小鼠中诱导中和抗体是必需的。
J Virol. 2000 Nov;74(22):10623-30. doi: 10.1128/jvi.74.22.10623-10630.2000.